SCHEMBL23635907

SCHEMBL23635907

COc1ccc(Cn2cccn2)cc1-c1nnc(NC(=O)OC(C)(C)C)s1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 12/20 0.50
HSD17B10 Q99714 8/20 0.50
HPGD P15428 6/20 0.50
RAB9A P51151 4/20 0.50
SMN1; SMN2 Q16637 4/20 0.50
NPC1 O15118 4/20 0.49
ALDH1A1 P00352 9/20 0.46
MEN1 O00255 4/20 0.46
KMT2A Q03164 4/20 0.46
MAPT P10636 2/20 0.45
USP2 O75604 1/20 0.45
GAA P10253 1/20 0.45
HTT P42858 1/20 0.45
TP53 P04637 1/20 0.44
CYP1A2 P05177 1/20 0.44
AHR P35869 1/20 0.44
GLS O94925 2/20 0.44
LMNA P02545 3/20 0.43
TSHR P16473 2/20 0.42
NPSR1 Q6W5P4 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30842170 1.00 KDM4E (0.50) KDM4EHSD17B10HPGDRAB9ASMN1; SMN2
SCHEMBL23631847 0.88 KDM4E (0.52) KDM4EHSD17B10HPGDRAB9ASMN1; SMN2
SCHEMBL23635969 0.81 KDM4E (0.47) KDM4EHSD17B10HPGDRAB9ASMN1; SMN2
SCHEMBL30842116 0.81 KDM4E (0.47) KDM4EHSD17B10HPGDRAB9ASMN1; SMN2
SCHEMBL23292496 0.78 HTT (0.43) KDM4EHSD17B10HPGDRAB9ASMN1; SMN2
SCHEMBL23292511 0.78 ALDH1A1 (0.54) KDM4EHSD17B10HPGDALDH1A1MEN1
SCHEMBL23635952 0.78 KAT7 (0.58) KAT7KAT6BKAT6A
SCHEMBL27097771 0.77 KDM4E (0.56) KDM4EHSD17B10HPGDRAB9ASMN1; SMN2
SCHEMBL23635944 0.75 KDM4E (0.53) KDM4EHSD17B10HPGDRAB9ASMN1; SMN2
SCHEMBL28867909 0.73 TSHR (0.70) HSD17B10HPGDRAB9ASMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11911372-B2 Compounds CTXT PTY LTD (AU) 2024-02-27 US disclosed
US-11911372-B2 Compounds CTXT PTY LTD (AU) 2024-02-27 US disclosed
US-20210213004-A1 Compounds CTXT PTY LTD (AU) 2021-07-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210213004-A1 Compounds SLC10A1, ABCB11, REN KDM4E 3932/4885HSD17B10 412/4885HPGD 1882/4885
US-11911372-B2 Compounds SLC10A1, ABCB11, REN KDM4E 3932/4885HSD17B10 412/4885HPGD 1882/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.